Lysine clonixinate versus dipyrone (metamizole) for the acute treatment of severe migraine attacks: A single-blind, randomized study

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 2 A, 2008, Pages 216-220

  Krymchantowski, Abouch Valenty ^a   Carneiro, Henrique ^b   Barbosa, Jackeline ^a   Jevoux, Carla ^a,c  

^a Headache Center of Rio   (Brazil)

^b Hospital Mater Dei   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Acute treatment; Dipyrone (metamizole); Lysine clonixinate; Migraine; Severe attacks

Indexed keywords

CLONIXIN LYSINE; DIPYRONE; INDOMETACIN;

ADULT; ARTICLE; BURNING SENSATION; CHEST PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; EMERGENCY WARD; FEMALE; HEADACHE; HEALTH CARE ORGANIZATION; HEARTBURN; HUMAN; INJECTION SITE PAIN; MALE; MIGRAINE; NAUSEA; PHOTOPHOBIA; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE;

EID: 45849127900     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000200015     Document Type: Article

References (31)

1. Stewart WF, Schechter A, Lipton RB. Migraine heterogeneity, disability, pain intensity and attack frequency and duration. Neurology 1994;44(Suppl 4):S24-S39.
2. Rasmussen BK. Epidemiology of headache. Cephalalgia 1995;15:45-68.
3. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2.Ed. Cephalalgia 2004;24(Suppl 1):S16-S149.
4. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia 1996;16:231-238.
5. Lipton RB, Stewart WF. Prevalence and impact of migraine. Neurol Clin 1997;15:1-13.
6. Peroutka SJ. The drug treatment of migraine. In Hardman JG, Limberd LE, Molinoff PB, Ruddon RW, Giman AG (Eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9.Ed. London:Pergamon; 1996:487-502.
7. Bigal ME, Bordini CA, Specialli JG. Tratamento da cefaléia em uma unidade de emergência da cidade de Ribeirão Preto. Arq Neuropsiquiatr 1999;57:813-819.
8. Bigal ME, Bordini CA, Tepper SJ, Specialli JG. Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double-blind, placebo-controlled study. Headache 2002;42:862-871.
9. Krymchantowski AV. Acute treatment of migraine: breaking the paradigm of monotherapy. BMC Neurology 2004;4:4.
10. Limmroth V, Przywara S. Analgesics. In Diener HC (Eed). Drug treatment of migraine and other headaches. Monogr Clin Neurosci, Vol 17. Basel:Karger, 2000:30-43.
11. Lipton RB, Stewart WF, Ryan RE, Saper J, Silberstein SD, Sheftell F. Ef-ficacy and safety of nonprescription combination of acetaminophen, aspirin aspirin and caffeine in alleviating headache pain of an acute migraine attack: three double-blind, randomized, placebo-controlled trials. Arch Neurol 1998;55:210-217.
12. Dahlof C, Bjorkman R. Diclofenac-K (50 and 100mg) and placebo in the acute treatment of migraine. Cephalalgia 1993;13:117-123.
13. Nestvold K, Kloster R, Partinen M, Sulkava R. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia 1985;5:115-119.
14. Kloster R, Nestvold K, Vilming S. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia 1992;12:169-171.
15. Pereyra Quintana JR, Levy DE, Brocato N. Comparacion del efecto analgésico del clonixinato de lisina com um hipnoanalgesico. El Dia Medico 1978;50:6-23.
16. Sierralta F. Clonixinato de lisina: interacciones com el sistema serotoninérgico y naloxona. Proc 9th Latinoamerican Congress of Pharmacology and Therapeutics, Abstracts. Santiago;1982:64.
17. Krymchantowski AV, Barbosa JS. Clonixinato de lisina injetável intravenoso para o tratamento agudo das enxaquecas: um estudo piloto aberto. Arq Neuropsiquiatr 1999;57:606-609.
18. Krymchantowski AV, Barbosa JS, Cheim C, Alves LA. Oral lysine clonixinate in the acute treatment of migraine: a double-blind, placebo-controlled study. Arq Neuropsiquiatr 2001;59:46-49.
19. Krymchantowski AV, Silva MT. Intravenous Lysine clonixinate for the acute treatment of severe migraine attacks: a double-blind, randomized, placebo-controlled study. Curr Therap Res 2003;64:505-513.
20. Paredes H, Solis R, Palacios J. The use of intravenous lysine clonixinate for rapid pain relief: an open clinical study. Curr Therap Res 1996;40:86-91.
21. Insel PA. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In Hardman JG, Limbird LE, Molinoff PB, Ruddon LW, Gilman AG (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. Nxinth Edition. New York:Mc-Graw Hill, 1996:617-657.
22. Bigal ME, Bordini CA, Speciali JG. Intravenous metamizol (dipyrone) in acute migraine treatment and in episodic tension-type headache headache: a placebo-controlled study. Cephalalgia 2001;21:90-95.
23. Stankov G, Schmieder G, Lechner FJ, Schinzel S. Observer-blind multicentre study with dipyrone versus tramadol in postoperative pain. Eur J Pain 1995;16:56-63.
24. Garcia-Alonso F, Gonzales de Suso MJ, Lopes-Alvarez M, Palop R. Comparative study of the efficacy of dipyrone, diclofenac sodium and pethidine in acute renal colic. Eur J Clin Pharmacol 1991;40:543-546.
25. Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment?. Headache 2002;42(Suppl 1):S3-S9.
26. Lorenzetti BB, Ferreira SH. Mode of analgesic action of dipyrone: direct antagonism of inflammatory hiperalgesia. Eur J Pharmacol 1985;114:375-381.
27. He X, Neugebauer V, Schaible Hg, Schmidt RF. New aspects of the mode of action of dipyrone. New Pharmacologial and Epidemiological Data in Analgesics Research. Adelaide, 3 Apr 1999. 1999:9-18.
28. Carlsson KH, Helmreich J, Jurna I. Activation of inhibition from the periaqueductal gray matter mediates central analgesic effect of metamizol (dipyrone). Pain 1986;27:373-390.
29. Tortorici V, Vanegas H. Putative role of medullary off- and on-cells in the antinociception produced by dipyrone (metamizol) administered systemically or microinjected into PAG. Pain 1994;57:197-205.
30. Orti E. Site-specific effects of the nonsteroidal anti-inflammatory drug lysine clonixinate on rat brain opioid receptors. Pharmacology 1999;58:190-199.
31. Kaube H, Hoskin KL, Goadsby PJ. Acetylsalicilic acid inhibits cerebral cortical vasodilatation caused by superior sagittal sinus stimulation in the cat. Eur J Neurol 1994;1:141-146.